PA
MAGN

PharVision Advisers’s Magnera Corp MAGN Stock Holding History

PharVision Advisers’s Portfolio MAGN Stock Details MAGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-29,209
Closed -$442K – 686
2025
Q4 		$442K Buy
+29,209
New +$338K 0.22% 79

Other funds holding MAGN

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
DCP
Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PharVision Advisers's MAGN Position: Q1 2026 in Review

PharVision Advisers sold out of Magnera Corp (MAGN) in Q1 2026, closing a stake of 29,209 shares — an estimated $442K sold.

PharVision Advisers first reported a position in MAGN in Q4 2025 and held it in 1 quarter. The position peaked at $442K in Q4 2025. 175 funds tracked by Wall St. Rank hold MAGN as of Q1 2026.

  • PharVision Advisers reported no remaining Magnera Corp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 29,209 Magnera Corp shares in Q1 2026, an estimated $442K.
  • PharVision Advisers first reported a position in Magnera Corp in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Magnera Corp position peaked at $442K in Q4 2025.
  • 175 funds tracked by Wall St. Rank held Magnera Corp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.